How to treat Lung cancer?

['Deungoen halaman nyoe']

Cara peu ubat kanker paru-paru?

Perawatan kanker paru-paru meugantung bak padum-padum boh faktor, termasok stadium kanker, jenis kanker paru-paru, dan kesehatan pasien secara umum.

Padim boh pilihan perawatan umum teumasok:

1. Operasi: nyoe seureng ji pileh untuk ji peu ubat kanker paru-paru tahap awai.

Dokter bedah geu peu jioh tumor ngon sebagian ubit jaringan sehat di seukitar jih.

2. Terapi radiasi: Radiasi berenergi tinggi dipakek untuk geupoh sel kanker ngon mengecilkan tumor.

Nyo jeut ji pakek sidroe atawa ji gabongkan ngen perawatan laen.

3. Kemoterapi: Perawatan nyo dipakek ubat untuk geupoh sel kanker.

Nyo jeut dijok intravena atau oral, dan seureng ji pakek dalam kombinasi ngen perawatan laen.

4. Terapi nyang dituju: Terapi nyoe ditujukan bak gen atau protein khusus nyang berkontribusi bak pertumbuhan ngon kelangsungan udep sel kanker.

Nyo seureng dipakek untuk kanker paru-paru lanjut atau metastatik.

5. Imunoterapi: perawatan nyoe membantu sistem kekebalan tubuh geuidentifikasi ngon geu serang sel kanker.

Nyo seureng dipakek untuk kanker paru-paru lanjut atau metastatik.

6. Terapi fotodinamis: perawatan nyoe geu pakek ubat yang geu aktifkan le cahaya untuk geupoh sel kanker.

Nyo seureng dipakek untuk kanker paru-paru tahap awai.

7. Terapi proton: nyoe adalah jenis terapi radiasi nyang geupakek proton daripada sinar-x untuk geupeutrok radiasi keu tumor.

Nyo seureng dipakek untuk kanker paru-paru tahap awai.

8. Uji klinis: Pasien mungken layak untuk berpartisipasi lam uji klinis nyang ji uji perawatan baro atawa kombinasi perawatan.

Penting untuk meutuka pilihan perawatan terbaik ngen tim kesehatan, kareuna rencana perawatan nyang paleng efektif akan meugantung bak situasi spesifik individu.

['Referensi[peusaneut nè]']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Chen JH, Wu J, Xu Q: The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther. , 4 (): 61.

Furuse K: [Photodynamic therapy of centrally located early-stage lung cancer]. Gan To Kagaku Ryoho. 1996, 23 (1): 27-30.

Gálffy G: [From rare mutations to classical ones, inhibition of signaling pathways in non-small cell lung cancer]. Magy Onkol. 2020, 64 (3): 196-204.

Magalhães M, Alvarez-Lorenzo C, Concheiro A, Figueiras A, Santos AC, Veiga F: RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers. Expert Opin Drug Deliv. 2018, 15 (10): 965-982.

Kataoka M, Fujiwara T, Tanaka N: [Gene therapy for lung cancer]. Nihon Geka Gakkai Zasshi. 2002, 103 (2): 244-9.

Jin C, Yang B: A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient. Case Rep Oncol. , 14 (1): 659-663.

Wang Y, Liu Q, Chen H, You J, Peng B, Cao F, Zhang X, Chen Q, Uzan G, Xu L, Zhang D: Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance. Anticancer Drugs. 2018, 29 (8): 748-755.

['Peuneugah: medis']

['Situs web nyoe hanya dipeutaba untuk tujuan pendidikan dan informasi dan hana merupakan nasehat medis atau layanan profesional.']

['Informasi nyang geubri hana jeut dipakek untuk mendiagnosis atau meuobati masalah kesehatan atau peunyaket, dan awak nyang mita nasehat medis pribadi harus berkonsultasi deungen dokter berlisensi.']

['Neuronal net nyang ji peuhase jawaban keu pertanyaan, khusus jih hana akurat wate ji peugah tentang konten numerik. miseu jih, jumlah ureung nyang ji diagnosa deungen peunyaket tertentu.']

['Sabe-sabe mita saran dari dokter atau penyedia kesehatan laen nyang berkualitas teuntang kondisi medis. Han tom neutilek nasihat medis profesional atawa neuterlambat mita jih kareuna na sesuatu nyang kaleuh neubaca bak situs web nyoe. Meunyo droeneuh pike droeneuh na darurat medis, hubungi 911 atawa neujak u ruang gawat darurat paleng toe langsong. Hana hubungan dokter-pasien nyang dipeuget le situs web nyoe atawa penggunaan jih. BioMedLib maupun karyawan jih, atawa kontributor situs web nyoe, hana dipeuget representasi, nyata atawa tersirat, teuntang informasi nyang geubri disinoe atawa penggunaan jih.']

['Peuneugah: hak cipta']

['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) geubi recourse keu ureung po hak cipta nyang yakin bahwa materi nyang deuh bak internet ji langgar hak awak nyan di miyup undang-undang hak cipta AS. ']

['Meunyo droeneuh yakin ngon get bahwa asoe atawa bahan nyang geupeutamöng lam hubôngan ngon website atawa layanan kamoe meulangga hak cipta droeneuh, droeneuh (atawa agen droeneuh) jeuet neukirém beuneuri keu kamoe ngön neulakèe mangat asoe atawa bahan nyan geusampôh, atawa geupeublok akses keujih.']

['Peumaklum haroh dikirim seucara tuleh deungen email (nging bagian "Kontak" untuk alamat email).']

['DMCA peurlee bahwa bewara droeneuh teuntang dugaan pelanggaran hak cipta teumasok informasi berikut: (1) deskripsi karya yang dilindungi hak cipta yang merupakan subjek klaim pelanggaran; (2) deskripsi konten yang diduga melanggar dan informasi yang cukup untuk memungkinkan kamoe untuk meutumeng konten; (3) informasi kontak untuk droeneuh, termasuk alamat, nomor telepon dan alamat email droeneuh; (4) pernyataan droeneuh bahwa droeneuh yakin bahwa konten yang diklaim hana diizinkan le pemilik hak cipta, atau agen jih, atau oleh operasi hukum apapun; ']

['(5) saboh pernyataan dari droeneuh, yang diteken deungen hukuman sumpah palsu, bahwa informasi lam pemberitahuan nyan akurat dan bahwa droeneuh na wewenang untuk menegakkan hak cipta yang diklaim dilanggar;']

['dan (6) tanda jaroe fisik atawa elektronik dari nyang po hak cipta atawa sidroe ureng nyang berwenang untuk bertindak atas nama nyang po hak cipta. ']

['Meunye hana neupeutamong mandum informasi di ateuh jeut keu akibat teulat meungurus keluhan droeneuh.']

['Kontak']

['Neukirem kheueh email keukamoe ateuh peue-peue nyang neutanyong atawa saran.']

How to treat lung cancer?

The treatment for lung cancer depends on several factors, including the stage of the cancer, the type of lung cancer, and the patient's overall health.

Some common treatment options include:

1. Surgery: This is often the preferred treatment for early-stage lung cancer.

The surgeon removes the tumor and a small portion of healthy tissue around it.

2. Radiation therapy: High-energy radiation is used to kill cancer cells and shrink tumors.

It can be used alone or in combination with other treatments.

3. Chemotherapy: This treatment uses drugs to kill cancer cells.

It can be given intravenously or or orally, and is often used in combination with other treatments.

4. Targeted therapy: This treatment targets specific genes or proteins that contribute to the growth and survival of cancer cells.

It is often used for advanced or metastatic lung cancer.

5. Immunotherapy: This treatment helps the immune system recognize and attack cancer cells.

It is often used for advanced or metastatic lung cancer.

6. Photodynamic therapy: This treatment uses a light-activated drug to kill cancer cells.

It is often used for early-stage lung cancer.

7. Proton therapy: This is a type of radiation therapy that uses protons instead of x-rays to deliver radiation to the tumor.

It is often used for early-stage lung cancer.

8. Clinical trials: Patients may be eligible to participate in clinical trials testing new treatments or combinations of treatments.

It is important to discuss the best treatment options with a healthcare team, as the most effective treatment plan will depend on the individual's specific situation.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.